Tasly Pharmaceutical Group Co Ltd
SSE:600535

Watchlist Manager
Tasly Pharmaceutical Group Co Ltd Logo
Tasly Pharmaceutical Group Co Ltd
SSE:600535
Watchlist
Price: 15.07 CNY
Market Cap: 22.5B CNY

Intrinsic Value

The intrinsic value of one Tasly Pharmaceutical Group Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 15.07 CNY, Tasly Pharmaceutical Group Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Tasly Pharmaceutical Group Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Tasly Pharmaceutical Group Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Tasly Pharmaceutical Group Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Tasly Pharmaceutical Group Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Tasly Pharmaceutical Group Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Tasly Pharmaceutical Group Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Tasly Pharmaceutical Group Co Ltd.

Explain Valuation
Compare Tasly Pharmaceutical Group Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Tasly Pharmaceutical Group Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tasly Pharmaceutical Group Co Ltd

Current Assets 7.8B
Receivables 2.8B
Other Current Assets 5B
Non-Current Assets 7.2B
Long-Term Investments 1.5B
PP&E 3.5B
Intangibles 2.1B
Other Non-Current Assets 123m
Current Liabilities 2B
Accounts Payable 329m
Accrued Liabilities 240m
Short-Term Debt 465m
Other Current Liabilities 1B
Non-Current Liabilities 614m
Long-Term Debt 226m
Other Non-Current Liabilities 388m
Efficiency

Free Cash Flow Analysis
Tasly Pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tasly Pharmaceutical Group Co Ltd

Revenue
8.3B CNY
Cost of Revenue
-2.9B CNY
Gross Profit
5.5B CNY
Operating Expenses
-4.3B CNY
Operating Income
1.1B CNY
Other Expenses
-40.6m CNY
Net Income
1.1B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Tasly Pharmaceutical Group Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
ROE is Increasing
Strong 3Y Average Gross Margin
Net Margin is Increasing
hidden
Profitability
Score

Tasly Pharmaceutical Group Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Tasly Pharmaceutical Group Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
hidden
Solvency
Score

Tasly Pharmaceutical Group Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Tasly Pharmaceutical Group Co Ltd

Wall Street analysts forecast Tasly Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tasly Pharmaceutical Group Co Ltd is 17.52 CNY with a low forecast of 14.95 CNY and a high forecast of 19.95 CNY.

Lowest
Price Target
14.95 CNY
1% Downside
Average
Price Target
17.52 CNY
16% Upside
Highest
Price Target
19.95 CNY
32% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Tasly Pharmaceutical Group Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Tasly Pharmaceutical Group Co Ltd stock?

The intrinsic value of one Tasly Pharmaceutical Group Co Ltd stock under the Base Case scenario is hidden CNY.

Is Tasly Pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 15.07 CNY, Tasly Pharmaceutical Group Co Ltd is hidden .

Back to Top